Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer's disease.
Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer's disease.
复制标题
DOI:
10.1007/s00401-022-02472-x
复制
发表时间:
2022-12
影响因子:
12.7
通讯作者:
Irwin DJ
中科院分区:
文献类型:
--
作者:
Arezoumandan S;Xie SX;Cousins KAQ;Mechanic-Hamilton DJ;Peterson CS;Huang CY;Ohm DT;Ittyerah R;McMillan CT;Wolk DA;Yushkevich P;Trojanowski JQ;Lee EB;Grossman M;Phillips JS;Irwin DJ
Alzheimer’s disease neuropathologic change (ADNC) is clinically heterogenous and can present with a classic multidomain amnestic syndrome or focal non-amnestic syndromes. Here, we investigated the distribution and burden of phosphorylated and C-terminally cleaved tau pathologies across hippocampal subfields and cortical regions among phenotypic variants of Alzheimer’s disease (AD). In this study, autopsy-confirmed patients with ADNC, were classified into amnestic (aAD, N=40) and non-amnestic (naAD, N=39) groups based on clinical criteria. We performed digital assessment of tissue sections immunostained for phosphorylated-tau (AT8 detects pretangles and mature tangles), D421-truncated tau (TauC3, a marker for mature tangles and ghost tangles), and E391-truncated tau (MN423, a marker that primarily detects ghost tangles), in hippocampal subfields and three cortical regions. Linear mixed-effect models were used to test regional and group differences while adjusting for demographics. Both groups showed AT8-reactivity across hippocampal subfields that mirrored traditional Braak staging with higher burden of phosphorylated-tau in subregions implicated as affected early in Braak staging. The burden of phosphorylated-tau and TauC3-immunoreactive tau in the hippocampus was largely similar between the aAD and naAD groups. In contrast, the naAD group had lower relative distribution of MN423-reactive tangles in CA1 (β=−0.2, SE=0.09, p=0.001) and CA2 (β=−0.25, SE=0.09, p=0.005) compared to the aAD. While the two groups had similar levels of phosphorylated-tau pathology in cortical regions, there was higher burden of TauC3 reactivity in sup/mid temporal cortex (β=0.16, SE=0.07, p=0.02) and MN423 reactivity in all cortical regions (β=0.4–0.43, SE=0.09, p<0.001) in the naAD compared to aAD. In conclusion, AD clinical variants may have a signature distribution of overall phosphorylated-tau pathology within the hippocampus reflecting traditional Braak staging; however, non-amnestic AD has greater relative mature tangle pathology in the neocortex compared to patients with clinical amnestic AD, where the hippocampus had greatest relative burden of C-terminally cleaved tau reactivity. Thus, varying neuronal susceptibility to tau-mediated neurodegeneration may influence the clinical expression of ADNC.
登录
查看更多内容
影响因子:
2.2
作者:
Khuebachova, M;Verzillo, V;Novak, M
通讯作者:
Novak, M
影响因子:
4.3
作者:
Giannini, Lucia A. A.;Xie, Sharon X.;Irwin, David J.
通讯作者:
Irwin, David J.
影响因子:
3.2
作者:
Irwin, David J.;Byrne, Matthew D.;Trojanowski, John Q.
通讯作者:
Trojanowski, John Q.
影响因子:
2.5
作者:
GOEDERT, M;JAKES, R;VANMECHELEN, E
通讯作者:
VANMECHELEN, E
影响因子:
2.8
作者:
García-Sierra, F;Wischik, CM;Mena, R
通讯作者:
Mena, R